We found that CD4+ T, CD8+ T, proliferating T cells (T-pro), and NK cells activated the anti-tumor function of TANs through TNF and IFNG, including cytotoxicity, cytokine production, chemotaxis, migration and IFNγ signaling (Figs. S20f, S21a). The gene discussed is CD8A; the disease is neoplasm.